Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Transition rates between chronic hepatitis B and diseases [13]

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

  Decompensated cirrhosis Hepatocellular cancer Transplantation Death (%)
Compensated cirrhosis 7.3 % 3.4 % 0.0 % 4.9
Decompensated cirrhosis 3.4 % 20.0 % 19.0
Hepatocellular cancer 25.0 % 43.3
transplantation 6.9